Search research articles
Contact Us
Filters
Showing results (491-500 of 602) with videos related to
Page
of 61
Sort By:
British Journal of Haematology
|
August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes
Jithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Blood
|
June 30, 2009
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens
Shaji Kumar, Sergio Giralt, Edward A Stadtmauer, et al.
Lancet (London, England)
|
December 15, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, et al.
American Journal of Hematology
|
June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma
Kenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
American Journal of Hematology
|
August 9, 2016
Outcomes of patients with renal monoclonal immunoglobulin deposition disease
Taxiarchis V Kourelis, Samih H Nasr, Angela Dispenzieri, et al.
American Journal of Hematology
|
October 26, 2017
Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma
Arjun Lakshman, Preet Paul Singh, S Vincent Rajkumar, et al.
American Journal of Hematology
|
January 11, 2022
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation
Nadine H Abdallah, Thomas Habermann, Francis K Buadi, et al.
Blood Cancer Journal
|
December 3, 2021
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Carlos Fernández de Larrea, Robert Kyle, Laura Rosiñol, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 31, 2021
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center
Laura A Evans, Ronald Go, Rahma Warsame, et al.
Bone Marrow Transplantation
|
December 23, 2017
Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis
Surbhi Sidana, Nidhi Tandon, Morie A Gertz, et al.
Page
of 61
Search research articles
Search
Showing results (491-500 of 602) with videos related to
Sort By:
Page
of 61
British Journal of Haematology
|
August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes
Jithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Blood
|
June 30, 2009
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens
Shaji Kumar, Sergio Giralt, Edward A Stadtmauer, et al.
Lancet (London, England)
|
December 15, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, et al.
American Journal of Hematology
|
June 26, 2026
Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma
Kenneth J C Lim, Shaji Kumar, Ricardo Parrondo, et al.
American Journal of Hematology
|
August 9, 2016
Outcomes of patients with renal monoclonal immunoglobulin deposition disease
Taxiarchis V Kourelis, Samih H Nasr, Angela Dispenzieri, et al.
American Journal of Hematology
|
October 26, 2017
Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma
Arjun Lakshman, Preet Paul Singh, S Vincent Rajkumar, et al.
American Journal of Hematology
|
January 11, 2022
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation
Nadine H Abdallah, Thomas Habermann, Francis K Buadi, et al.
Blood Cancer Journal
|
December 3, 2021
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Carlos Fernández de Larrea, Robert Kyle, Laura Rosiñol, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 31, 2021
The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center
Laura A Evans, Ronald Go, Rahma Warsame, et al.
Bone Marrow Transplantation
|
December 23, 2017
Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis
Surbhi Sidana, Nidhi Tandon, Morie A Gertz, et al.
Page
of 61